Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Prospective Multicenter Observational Study for the Evaluation of the Efficacy of the Cordis Enterprise(TM) Self-expanding Intracranial Stent: Enterprise Stent Aneurysm Treatment (ESAT) Study

NCT00879580 is registered in ClinicalTrials.gov with Codman & Shurtleff as lead sponsor.

NCT NCT00879580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00879580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Prospective Multicenter Observational Study for the Evaluation of the Efficacy of the Cordis Enterprise(TM) Self-expanding Intracranial Stent: Enterprise Stent Aneurysm Treatment (ESAT) Study
Lead sponsor
Codman & Shurtleff
Phase
Observational
Overall status
Completed
Start date
February 28, 2009
Completion date
August 31, 2013
Enrollment
133 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial aneurysm